{"nct_id":"NCT07085767","title":"Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer","status":"NOT_YET_RECRUITING","status_verified_date":"2025-09","start_date":"2025-10-31","start_date_type":"ESTIMATED","primary_completion_date":"2028-12","primary_completion_date_type":"ESTIMATED","completion_date":"2032-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["OLMA"]}